Post-transplant lymphoproliferative disorders (PTLD) following solid organ transplantation: The role of combination chemotherapy.

被引：0
|
作者：
Cullis, JO
McCarthy, M
Heaton, N
Williams, R
JanMohamed, R
Pagliuca, A
Mufti, GJ
机构：
[1] UNIV LONDON KINGS COLL HOSP,DEPT HAEMATOL MED,LONDON,ENGLAND
[2] UNIV LONDON KINGS COLL HOSP,INST LIVER STUDIES,LONDON,ENGLAND
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：359 / 359
页数：1
相关论文
共 50 条
  • [21] Low-dose chemotherapy for refractory EBV associated post-transplant lymphoproliferative disease (PTLD) following solid organ transplant (SOT) in children.
    Gross, TG
    Park, J
    Bucuvalas, J
    Langnas, A
    Kaufman, S
    McDonald, R
    Goldman, F
    Lynch, JC
    BLOOD, 2002, 100 (11) : 159A - 160A
  • [22] Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD)
    Nalesnik, MA
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1998, 20 (3-4): : 325 - 342
  • [23] CONCURRENT SUBTYPES OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS AFTER SOLID ORGAN TRANSPLANT
    Dalal, Mansi
    Liu, Catherine
    Drew, Kristin
    Slayton, William
    Shih, Renata
    Collins, William
    Jolley, Christopher
    Upadhyay, Kiran
    Rajderkar, Dhanashree
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S186 - S187
  • [24] Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD)
    Michael A. Nalesnik
    Springer Seminars in Immunopathology, 1998, 20 : 325 - 342
  • [25] Is rituximab (R) the optimal therapeutic intervention (TI) for post-transplant lymphoproliferative disorder (PTLD) following solid organ transplant (SOT)?
    Tsao, R. E.
    Jin, T.
    Richendollar, B.
    Hsi, E.
    Pohlman, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [26] Post-transplant lymphoproliferative disorder (PTLD)
    Petrik, D. W.
    Lai, R.
    Pearcey, R. G.
    CLINICAL ONCOLOGY, 2007, 19 (02) : 163 - 164
  • [27] Salvage chemotherapy for refractory or relapsed post-transplant lymphoproliferative disorder in patients after solid organ transplantation with a combination of carboplatin and etoposide
    Oertel, SH
    Papp-Váry, M
    Anagnostopoulos, I
    Hummel, MW
    Jonas, S
    Riess, HB
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 123 (05) : 830 - 835
  • [28] Post-Transplant Lymphoproliferative Disorders in Pediatric Solid Organ Transplant Recipients - Interim Analysis of Trial Ped-PTLD-Pilot-2005
    Maecker-Kolhoff, B.
    Kreipe, H.
    Henke-Gendo, C.
    Beier, R.
    Meissner, B.
    Klein, C.
    TRANSPLANTATION, 2012, 94 (10) : 25 - 25
  • [29] Proposed prognostic model for survival in solid organ transplant recipients with post transplant lymphoproliferative disorders (PTLD).
    Ghobrial, IM
    Habermann, TM
    Maurer, MJ
    Geyer, SM
    Macon, W
    Ristow, K
    Larson, T
    Ansell, SM
    Gores, G
    Stegall, M
    Walker, R
    McGregor, C
    BLOOD, 2003, 102 (11) : 392A - 392A
  • [30] Post-Transplant Lymphoproliferative Disorders Following Alemtuzumab Induction in Kidney Transplantation
    Sawhney, H.
    Charif, R.
    Galliford, J.
    Mclean, A.
    Taube, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
12345